Brenda Wolling

Brenda Wolling serves as the Executive Director of Regulatory Affairs at Cellectar Biosciences, Inc. since January 2022. With a robust background in regulatory affairs, Brenda has held significant roles including Regulatory Affairs Subject Matter Expert at the Biomedical Advanced Research and Development Authority from May 2018 to January 2022, and Director of Regulatory Affairs for the BioDefense Division at Emergent BioSolutions from June 2013 to May 2018. Previous experience includes positions such as Associate Director of Regulatory Affairs at Wellstat Management Company and MedImmune, and Executive Director of Regulatory Affairs at MiddleBrook Pharmaceuticals. Brenda began her career in clinical roles, including as a Clinical Pharmacology Associate at Otsuka. Brenda holds a BS in Statistics and Business Administration from Cabrini University.